Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common (2009 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Dividends Paid - Common for 10 consecutive years, with $12.0 million the latest figure, recorded in Q1 2018.

• Quarterly Dividends Paid - Common fell 96.53% year-over-year to $12.0 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $12.0 million (down 98.67% YoY) and the FY2018 annual result came in at $12.0 million, down 98.67% from the prior year.
• Dividends Paid - Common eased to $12.0 million in Q1 2018 per TEVA's latest filing, from $87.0 million in the prior quarter.
• Over the last five years, Dividends Paid - Common for TEVA reached as high as $346.0 million in Q4 2016 and fell as low as $12.0 million in Q1 2018.
• A 5-year average of $266.3 million and a median of $291.0 million in 2014 frame the typical range for Dividends Paid - Common.
• Annual changes were most pronounced in 2016 — Dividends Paid - Common climbed 19.31% — and 2018, when it tumbled 96.53%.
• Year by year, Dividends Paid - Common stood at $272.0 million in 2014, then advanced by 6.62% to $290.0 million in 2015, then grew by 19.31% to $346.0 million in 2016, then tumbled by 74.86% to $87.0 million in 2017, then plunged by 86.21% to $12.0 million in 2018.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $12.0 million, $87.0 million, and $123.0 million for Q1 2018, Q4 2017, and Q3 2017 respectively.